PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
BMRN vs. BMTX
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

BMRN vs. BMTX

Last updated Apr 2, 2026

Compare and contrast key facts about BioMarin Pharmaceutical Inc. (BMRN) and BM Technologies, Inc. (BMTX).

Performance

BMRN vs. BMTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BioMarin Pharmaceutical Inc. (BMRN) and BM Technologies, Inc. (BMTX). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

BMRN vs. BMTX - Yearly Performance Comparison

2026 (YTD)
BMRN
BioMarin Pharmaceutical Inc.		-1.53%
BMTX
BM Technologies, Inc.		0.00%

Fundamentals

Total Revenue (TTM)

BMRN:

$3.22B

BMTX:

$57.66M

Gross Profit (TTM)

BMRN:

$2.48B

BMTX:

$14.95M

EBITDA (TTM)

BMRN:

$613.03M

BMTX:

-$6.70M

Returns By Period

BMRN

1D
1.33%
1M
-4.18%
YTD
-3.69%
6M
4.34%
1Y
-15.75%
3Y*
-16.19%
5Y*
-5.96%
10Y*
-3.84%

BMTX

1D
0.00%
1M
0.00%
YTD
—
6M
—
1Y
—
3Y*
—
5Y*
—
10Y*
—
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

BioMarin Pharmaceutical Inc.

BM Technologies, Inc.

Often compared with BMRN:
BMRN vs. CRSPBMRN vs. CPRXBMRN vs. RCKTBMRN vs. VRTXBMRN vs. JAZZBMRN vs. KNSABMRN vs. NBIX
Often compared with BMTX:
BMTX vs. TMDXBMTX vs. VTIBMTX vs. WMBBMTX vs. PM

Return for Risk

BMRN vs. BMTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
BMRN
BMRN Risk / Return Rank: 1919
Overall Rank
BMRN Sharpe Ratio Rank: 2121
Sharpe Ratio Rank
BMRN Sortino Ratio Rank: 1919
Sortino Ratio Rank
BMRN Omega Ratio Rank: 2020
Omega Ratio Rank
BMRN Calmar Ratio Rank: 1313
Calmar Ratio Rank
BMRN Martin Ratio Rank: 2020
Martin Ratio Rank
BMTX
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BMRN vs. BMTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for BioMarin Pharmaceutical Inc. (BMRN) and BM Technologies, Inc. (BMTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

BMRNBMTXDifference

Sharpe ratio

Return per unit of total volatility

-0.45

—

—

Sortino ratio

Return per unit of downside risk

-0.48

—

—

Omega ratio

Gain probability vs. loss probability

0.94

—

—

Calmar ratio

Return relative to maximum drawdown

-0.77

—

—

Martin ratio

Return relative to average drawdown

-1.12

—

—

Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BMRN vs. BMTX - Sharpe Ratio Comparison

Loading graphics...

Sharpe Ratios by Period

BMRNBMTXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.45

—

—

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.19

—

—

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.11

—

—

Sharpe Ratio (All Time)

Calculated using the full available price history

0.12

—

—

Dividends

BMRN vs. BMTX - Dividend Comparison

Neither BMRN nor BMTX has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

BMRN vs. BMTX - Drawdown Comparison

The maximum BMRN drawdown since its inception was -90.58%, which is greater than BMTX's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for BMRN and BMTX.

Loading graphics...

Drawdown Indicators

BMRNBMTXDifference

Max Drawdown

Largest peak-to-trough decline

-90.58%

0.00%

-90.58%

Max Drawdown (1Y)

Largest decline over 1 year

-24.68%

—

—

Max Drawdown (5Y)

Largest decline over 5 years

-56.12%

—

—

Max Drawdown (10Y)

Largest decline over 10 years

-60.73%

—

—

Current Drawdown

Current decline from peak

-61.62%

0.00%

-61.62%

Average Drawdown

Average peak-to-trough decline

-45.39%

0.00%

-45.39%

Ulcer Index

Depth and duration of drawdowns from previous peaks

16.93%

—

—

Volatility

BMRN vs. BMTX - Volatility Comparison

Loading graphics...

Volatility by Period

BMRNBMTXDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.98%

—

—

Volatility (6M)

Calculated over the trailing 6-month period

25.07%

—

—

Volatility (1Y)

Calculated over the trailing 1-year period

35.69%

0.00%

+35.69%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

32.18%

0.00%

+32.18%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

35.64%

0.00%

+35.64%

Financials

BMRN vs. BMTX - Financials Comparison

This section allows you to compare key financial metrics between BioMarin Pharmaceutical Inc. and BM Technologies, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.

Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities

0.00200.00M400.00M600.00M800.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
874.57M
14.08M
(BMRN) Total Revenue
(BMTX) Total Revenue
Values in USD except per share items